HILLARY DOUSSAN: Open Payments
NPI 1831448653 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 44 payments from 12 companies in 2025. Trend: 2023 $663 · 2024 $1,024 · 2025 $717
Food & beverage: $617Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $200 |
| ABBVIE INC. | 12 | $167 |
| Regeneron Healthcare Solutions, Inc. | 5 | $111 |
| Incyte Corporation | 3 | $66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $29 |
| GENZYME CORPORATION | 1 | $28 |
| UCB, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| LEO Pharma Inc. | 1 | $17 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, OPZELURA, ILUMYA, Bimzelx, Sotyktu.
Industry payments across FL — which companies pay providers there.
